Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells von Dejligbjerg, Marielle, Grauslund, Morten, Litman, Thomas, Collins, Laura, Qian, Xiaozhong, Jeffers, Michael, Lichenstein, Henri, Jensen, Peter Buhl, Sehested, Maxwell

Volltext

The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo von TUMBER, Anthony, COLLINS, Laura S, PETERSEN, Kamille Dumong, THOUGAARD, Annemette, CHRISTIANSEN, Sanne J, DEJLIGBJERG, Marielle, JENSEN, Peter Buhl, SEHESTED, Maxwell, RITCHIE, James W. A

Volltext

Combining Etoposide and Dexrazoxane Synergizes with Radiotherapy and Improves Survival in Mice with Central Nervous System Tumors von HOFLAND, Kenneth Francis, THOUGAARD, Annemette Vinding, DEJLIGBJERG, Marielle, JENSEN, Lars H, KRISTJANSEN, Paul E. G, RENGTVED, Pia, SEHESTED, Maxwell, JENSEN, Peter Buhl

Volltext

Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells von Jensen, Lars H, Dejligbjerg, Marielle, Hansen, Lasse T, Grauslund, Morten, Jensen, Peter B, Sehested, Maxwell

Volltext

Characterisation of cytotoxicity and DNA damage induced by the topoisomeras IIE-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells von Jensen, Lars H, Dejligbjerg, Marielle, Hansen, Lasse T, Grauslund, Morten, Jensen, Peter B, Sehested, Maxwell

Volltext